Biovica International Investor Relations Material
Latest events
Q3 2025
Biovica International
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Biovica International
Access all reports
Biovica International AB, a biotechnology company, develops and commercializes blood-based biomarker assays that enhance the monitoring of cancer therapies and predict patient outcome. The company's focus is on prediction of treatment efficacy and prognosis, thereby providing physicians with objective decision-making tools that enable informed treatment choice. The company is based in Uppsala, Sweden.
Key slides for Biovica International
Q1 2025
Biovica International
Q1 2025
Biovica International
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
BIOVIC
Country
🇸🇪 Sweden